Cite

HARVARD Citation

    Basset-Séguin, N. et al. (2017). Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trial. European journal of cancer. pp. 334-348. [Online]. 
  
Back to record